Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
PaperCitations, authors & open-access status
A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 133 citations, 2010 year and closed oa status.
133
Citations
2010
Year
closed
OA Status